Sprint Bioscience AB (publ) (STO:SPRINT)

Sweden · Delayed Price · Currency is SEK

2.850

-0.010 (-0.35%)

Sep 22, 2026, 5:24 PM CET

Sprint Bioscience AB Financials Overview

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	139.36	167.39	66.14	51.69	0.08	35.03
Revenue Growth	133.86%	153.07%	27.97%	62171.08%	-99.76%	82.48%
Gross Profit	131.98	154.31	37.8	42.99	-12.85	24.59
Operating Income	78.9	97.55	-18.77	-1.32	-60.62	-25.47
Net Income	75.65	91.74	-18.28	-0.44	-60.17	-25.08
Earnings Per Share	0.71	0.98	-0.26	-0.01	-1.43	-0.87
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Sweden	0.01	0.02	0.04	0.05	-
USA	167.16	65.63	50.45	0.04	35.11
Total	167.17	65.64	50.49	0.08	35.11

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	93.26	126.7	25.06	49.93	29.49	70.64
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	93.26	126.7	25.06	49.93	29.49	70.64
Net Cash Growth	278.24%	405.68%	-49.82%	69.31%	-58.25%	313.73%
Net Cash Per Share	0.88	1.37	0.36	0.72	0.70	2.45

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	68.95	83.53	-23.36	22.87	-59.05	-40.12
Capital Expenditures	-0.5	-0.09	-1.3	-2.45	-	-2.71
Free Cash Flow	68.45	83.44	-24.65	20.42	-59.05	-42.82
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	94.70%	92.19%	57.16%	83.17%	-	70.21%
Operating Margin	56.62%	58.28%	-28.37%	-2.56%	-73031.32%	-72.70%
Pretax Margin	54.29%	54.81%	-27.63%	-0.85%	-72493.98%	-71.61%
Profit Margin	54.29%	54.81%	-27.63%	-0.85%	-72493.98%	-71.61%
FCF Margin	49.11%	49.85%	-37.27%	39.50%	-71149.40%	-122.26%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	4.03	1.69	-	-	-	-
Forward PE	11.70	5.88	1.76	2.48	11.06	2.01
P/FCF Ratio	4.39	1.86	-	5.93	-	-
PS Ratio	2.16	0.93	1.67	2.34	265.47	5.45